📰 Randomized Double Blind News
Page 4 - Randomized Double Blind News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Randomized Double Blind. Real-time updates on events, politics, business and more.
March 14, 2022
Supreme Court issues notice to Centre over homeopathic immune booster guidelines
February 21, 2022
Are you looking for a natural way to boost your testosterone levels? Check out our top brand reviews 2023 for this year here.
February 17, 2022
The FDA recommended that Covis Pharma's premature birth drug, Makena, be taken off the market. The company has refused. Covis has continued to promote Makena, emphasizing a need by Black women, who are most at risk of preterm births.
February 13, 2022
Are you looking to spice up your sex life this year? Read on to check out our top picks for male enhancement pills in 2023.
January 24, 2022
Find out the best nootropic stacks and brain supplements of 2022 based on user reviews and other forms of user engagement.
January 15, 2022
(Screenshot from DOSTv Facebook) MANILA - A medical doctor and project leader of the study on lagundi as adjuvant therapy for mild Covid-19 reminded the public that there is a prescribed dosage for the herbal medicine that treats cough and asthma. Department of Science and Technology (DOST) Secretary Fortunato de la Pena, in a taped report aired Friday afternoon, said the prescribed dosages will ensure that treatment using lagundi will render positive results. Citing the recommendations of Dr. C...
December 1, 2021
/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) and Selecta Biosciences, Inc. (NASDAQ: SELB), today announced the completion of...
December 1, 2021
/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) and Selecta Biosciences, Inc. (NASDAQ: SELB), today announced the completion of...
December 1, 2021
STOCKHOLM, Dec. 1, 2021 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) and Selecta Biosciences, Inc. (NASDAQ: SELB), today announced the completion of enrolment for DISSOLVE